Investing In a Better Future

If you’ve come to this page, we hope you are as excited about Bicycle as we are. Our goal is to be one of the world’s leading solid tumor therapeutics companies. Please give us a call or send us an email if you have questions about our science, clinical programs, strategy or any other aspect of the Bicycle story.
Press
Date
Title
Date
09/19/22
Title
Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT8009 Program in Molecular Cancer Therapeutics
Date
09/07/22
Title
Bicycle Therapeutics Announces BT5528 Phase I Dose Escalation Results in Patients with Advanced Solid Tumors
Date
09/06/22
Title
Bicycle Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Date
08/04/22
Title
Bicycle Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update